EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudiePragmatische StudieVergleichsstudieMultizentrische StudieOpen Access · CC BY 4.0

Treatment of latent tuberculosis infection in migrants in primary care versus secondary care

Matthew Burman, Dominik Zenner, Andrew J Copas, Lara Goscé iD, Hassan Haghparast-Bidgoli, Peter J White iD, Vicky Hickson, Opal Greyson, Duncan Trathen, Richard Ashcroft, Adrian R Martineau, Ibrahim Abubakar iD und 2 weitere

European Respiratory Journal · 2024

DOI: 10.1183/13993003.01733-2023 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Respiratory Journal, 2024. Verfasst von Matthew Burman und 13 weiteren Autor:innen. Beteiligte Einrichtung: Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. Hauptthemen laut MEDLINE: Latent Tuberculosis, Primary Health Care, Secondary Health Care, Transients and Migrants. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Barts Charity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Control of latent tuberculosis infection (LTBI) is a priority in the World Health Organization strategy to eliminate TB. Many high-income, low TB incidence countries have prioritised LTBI screening and treatment in recent migrants. We tested whether a novel model of care, based entirely within primary care, was effective and safe compared to secondary care.

Methods

This was a pragmatic cluster-randomised, parallel group, superiority trial ( ClinicalTrials.gov : NCT03069807 ) conducted in 34 general practices in London, UK, comparing LTBI treatment in recent migrants in primary care to secondary care. The primary outcome was treatment completion, defined as taking ≥90% of antibiotic doses. Secondary outcomes included treatment acceptance, adherence, adverse effects, patient satisfaction, TB incidence and a cost-effectiveness analysis. Analyses were performed on an intention-to-treat basis.

Results

Between September 2016 and May 2019, 362 recent migrants with LTBI were offered treatment and 276 accepted. Treatment completion was similar in primary and secondary care (82.6% versus 86.0%; adjusted OR (aOR) 0.64, 95% CI 0.31–1.29). There was no difference in drug-induced liver injury between primary and secondary care (0.7% versus 2.3%; aOR 0.29, 95% CI 0.03–2.84). Treatment acceptance was lower in primary care (65.2% (146/224) versus 94.2% (130/138); aOR 0.10, 95% CI 0.03–0.30). The estimated cost per patient completing treatment was lower in primary care, with an incremental saving of GBP 315.27 (95% CI 313.47–317.07).

Conclusions

The treatment of LTBI in recent migrants within primary care does not result in higher rates of treatment completion but is safe and costs less when compared to secondary care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Latent TuberculosisPrimary Health CareSecondary Health CareTransients and MigrantsCost-Benefit AnalysisAntitubercular AgentsHumansFemaleMaleAdultLondonMiddle AgedYoung AdultMedication AdherenceAdolescent

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Homerton Healthcare NHS Foundation Trust, London, UK.
  • Institute for Global Health, University College London, London, UK.
  • MRC Centre for Global Infectious Disease Analysis and NIHR Health Protection Research Unit in Modelling and Health Economics, Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
  • Modelling and Economics Unit, UK Health Security Agency, London, UK.
  • Newham Clinical Commissioning Group, London, UK.

ORCID-Profile: Lara Goscé, Peter J White, Ibrahim Abubakar

Förderung

  • Wellcome Trust
  • Medical Research Council
  • Barts Charity

Zitieren

APA

Burman, M., Zenner, D., Copas, A. J., Goscé, L., Haghparast-Bidgoli, H., White, P. J., Hickson, V., Greyson, O., Trathen, D., Ashcroft, R., Martineau, A. R., Abubakar, I., Griffiths, C. J., & Kunst, H. (2024). Treatment of latent tuberculosis infection in migrants in primary care versus secondary care. European Respiratory Journal. https://doi.org/10.1183/13993003.01733-2023

Vancouver

Burman M, Zenner D, Copas AJ, Goscé L, Haghparast-Bidgoli H, White PJ, et al. Treatment of latent tuberculosis infection in migrants in primary care versus secondary care. European Respiratory Journal. 2024. doi:10.1183/13993003.01733-2023

BibTeX
@article{Burman2024,
  author = {Burman, Matthew and Zenner, Dominik and Copas, Andrew J and Goscé, Lara and Haghparast-Bidgoli, Hassan and White, Peter J and Hickson, Vicky and Greyson, Opal and Trathen, Duncan and Ashcroft, Richard and Martineau, Adrian R and Abubakar, Ibrahim and Griffiths, Christopher J and Kunst, Heinke},
  title = {Treatment of latent tuberculosis infection in migrants in primary care versus secondary care},
  journal = {European Respiratory Journal},
  year = {2024},
  doi = {10.1183/13993003.01733-2023}
}
Kostenlos starten →